Imcyse

Avenue du Pré-Aily 14
4031 Liège Angleur
BE
Imcyse
Foundation date
10/08/2010
Sector
#Biotechnology - TherapeuticsSubsector
Therapeutic areas
- #Diseases of the blood and blood-forming organs - immune disorders
- #Infectious and parasitic diseases
Imcyse develops active targeted immune therapies (ImotopesÔ) that locally inhibit the immune cells involved in the destruction of the diseased organ. The targeted approach and memory effect of the Imcyse technology help to prevent and cure diseases with no current therapeutic alternative, caused by disruptions of the immune system without impairing the patient’s immune defences.
Upcoming events
All events-
0106 '23
KNOWLEDGE FOR GROWTH 2023
Event by: flanders.bio -
0506 '23
BIO International Convention 2023
Event by: Biotechnology Innovation Organisation -
0604 '23
Innovation for Health 2023
Event by: Hyphen Projects
Latest news
More news-
Cerba Research & Teddy Lab sign Memorandum of Understanding on entering into a discussion for Joint Venture
7 hours ago
Read more
-
Novalis Biotech invests in Rarity Bioscience's ultra sensitive genomics technology
1 day ago
Read more
-
Fat creates an ideal environment for metastatic breast tumors
1 day ago
Read more
Jobs
More jobs-
07/02/23
Brussels
Postdoctoral position in cancer immunology and the tumor immune microenvironment
Permanent
VIB -
-